• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉血运重建可降低稳定型冠状动脉疾病患者血浆N末端B型利钠肽原浓度。

Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.

作者信息

McClure Samuel J, Gall Scott, Schechter Clyde B, Kearney Mark, Zaman Azfar G

机构信息

Department of Cardiology, Freeman Hospital, Newcastle-upon-Tyne, United Kingdom.

出版信息

J Am Coll Cardiol. 2007 Jun 26;49(25):2394-7. doi: 10.1016/j.jacc.2007.02.064. Epub 2007 Jun 11.

DOI:10.1016/j.jacc.2007.02.064
PMID:17599601
Abstract

OBJECTIVES

The purpose of this work was to assess the effect of percutaneous coronary revascularization (PCR) on plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentration.

BACKGROUND

Left ventricular (LV) dysfunction is associated with increased plasma natriuretic peptide concentrations. The effect of ischemia resolution on plasma natriuretic peptide is not known.

METHODS

Twenty-six patients with stable angina, normal LV systolic function, and isolated stenoses of the left anterior descending (LAD) coronary artery were studied. All patients had angiographically and physiologically significant lesions defined by cine-angiography and intracoronary pressure wire.

RESULTS

After revascularization, 24 patients demonstrated significant decrease in mean plasma NT-proBNP 8 weeks after PCR (from 177.2 +/- 190.8 pg/ml to 105.0 +/- 92.4 pg/ml, p = 0.03). The mean decrease in log NT-proBNP was 0.533, corresponding to geometric mean decrease of NT-proBNP by a factor of 59% (95% confidence interval 48.2% to 71.4%, p < 0.00005). Reduction in NT-proBNP was independent of change in LV systolic function.

CONCLUSIONS

This study demonstrates that removal of fixed LAD stenosis reduces plasma NT-proBNP concentration. This has implications for interpretation of natriuretic peptide levels in clinical settings and as screening tool for LV systolic dysfunction.

摘要

目的

本研究旨在评估经皮冠状动脉血运重建术(PCR)对血浆N端前脑钠肽(NT-proBNP)浓度的影响。

背景

左心室(LV)功能障碍与血浆利钠肽浓度升高有关。缺血缓解对血浆利钠肽的影响尚不清楚。

方法

对26例稳定型心绞痛、左心室收缩功能正常且左前降支(LAD)冠状动脉孤立性狭窄的患者进行研究。所有患者均经电影血管造影和冠状动脉内压力导丝确定存在血管造影和生理学上有意义的病变。

结果

血运重建后,24例患者在PCR术后8周时血浆NT-proBNP均值显著降低(从177.2±190.8 pg/ml降至105.0±92.4 pg/ml,p = 0.03)。NT-proBNP对数均值下降0.533,相当于NT-proBNP几何均值下降59%(95%置信区间48.2%至71.4%,p < 0.00005)。NT-proBNP的降低与左心室收缩功能的变化无关。

结论

本研究表明,解除LAD固定狭窄可降低血浆NT-proBNP浓度。这对临床环境中利钠肽水平的解读以及作为左心室收缩功能障碍的筛查工具具有重要意义。

相似文献

1
Percutaneous coronary revascularization reduces plasma N-terminal pro-B-type natriuretic peptide concentration in stable coronary artery disease.经皮冠状动脉血运重建可降低稳定型冠状动脉疾病患者血浆N末端B型利钠肽原浓度。
J Am Coll Cardiol. 2007 Jun 26;49(25):2394-7. doi: 10.1016/j.jacc.2007.02.064. Epub 2007 Jun 11.
2
The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease.经皮冠状动脉血运重建术对稳定型冠状动脉疾病患者血浆N末端B型利钠肽原水平的影响
Indian Heart J. 2018 Mar-Apr;70(2):282-288. doi: 10.1016/j.ihj.2017.08.005. Epub 2017 Aug 16.
3
The severity of coronary artery disease and reversible ischemia revealed by N-terminal pro-brain natriuretic peptide in patients with unstable angina and preserved left ventricular function.N末端脑钠肽前体揭示的不稳定型心绞痛且左心室功能保留患者的冠状动脉疾病严重程度及可逆性缺血
Peptides. 2014 Feb;52:143-8. doi: 10.1016/j.peptides.2013.12.018. Epub 2014 Jan 8.
4
N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.N末端B型利钠肽原水平:与动态队列中经超声心动图测定的左心室舒张功能的相关性
J Am Soc Echocardiogr. 2006 Aug;19(8):1017-25. doi: 10.1016/j.echo.2006.03.012.
5
[Asymptomatic ischemic heart dysfunction, echocardiographic changes and NT-proBNP during 2-years observation].[两年观察期内无症状性缺血性心脏功能障碍、超声心动图变化及N末端B型利钠肽原]
Przegl Lek. 2014;71(7):378-83.
6
Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.稳定型冠状动脉疾病患者脑钠肽(BNP)与N末端B型利钠肽原分泌及冠状动脉狭窄程度的直接比较。
Circ J. 2007 Apr;71(4):499-505. doi: 10.1253/circj.71.499.
7
N-terminal pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization.N端前B型利钠肽作为重复冠状动脉血运重建的预测指标。
Int J Cardiol. 2008 Jun 6;126(3):322-32. doi: 10.1016/j.ijcard.2007.04.007. Epub 2007 Jun 4.
8
Is N-terminal pro B-type natriuretic peptide (NT-proBNP) a useful screening test for angiographic findings in patients with stable coronary disease?N端前B型利钠肽(NT-proBNP)对稳定型冠心病患者的血管造影结果而言是一项有用的筛查检测吗?
Am Heart J. 2006 Mar;151(3):712.e1-712.e7. doi: 10.1016/j.ahj.2005.12.009.
9
[NT-proBNP and echocardiography for long-term left ventricular function assessment after acute myocardial infarction treated with primary angioplasty].[N末端B型利钠肽原与超声心动图用于直接经皮冠状动脉腔内血管成形术治疗急性心肌梗死后左心室功能的长期评估]
Pol Merkur Lekarski. 2006 Mar;20(117):289-92.
10
Can we predict the severity of coronary artery disease in patients with stable angina using NT-ProBNP?我们能否使用N末端B型利钠肽原(NT-ProBNP)来预测稳定型心绞痛患者冠状动脉疾病的严重程度?
Anadolu Kardiyol Derg. 2006 Sep;6(3):235-8.

引用本文的文献

1
The Effects of Percutaneous Coronary Intervention on Biomarkers and Quality of Life in Patients With Chronic Total Coronary Artery Obstruction.经皮冠状动脉介入治疗对慢性完全性冠状动脉阻塞患者生物标志物及生活质量的影响
Cardiol Res. 2023 Feb;14(1):69-78. doi: 10.14740/cr1455. Epub 2023 Feb 25.
2
The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease.经皮冠状动脉血运重建术对稳定型冠状动脉疾病患者血浆N末端B型利钠肽原水平的影响
Indian Heart J. 2018 Mar-Apr;70(2):282-288. doi: 10.1016/j.ihj.2017.08.005. Epub 2017 Aug 16.
3
Plasma ProBNP Is Not a Specific Marker for Transient Myocardial Ischemia.
血浆脑钠肽前体并非短暂性心肌缺血的特异性标志物。
J Clin Med Res. 2015 Jul;7(7):506-10. doi: 10.14740/jocmr2024w. Epub 2015 May 8.
4
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases.N-末端脑利钠肽前体在心力衰竭和其他心血管疾病中的临床应用。
Heart Fail Rev. 2010 Jul;15(4):293-304. doi: 10.1007/s10741-009-9142-1.